Company intelligence
ENBIOSIS Biotechnology
Inner Voice of Your Body
About ENBIOSIS Biotechnology
Enbiosis is the World's First Digital Twin and AI-Powered Nutraceutical Formulation Engine. We use constraint-based metabolic modelling and genome-scale metabolic models to design clinically validated, food-grade nutraceutical formulations. Our platform maps microbiome-linked metabolic disruptions, identifies biological targets, and engineers precise formulations in silico before a single ingredient is selected. Each formulation is developed to FDA and EFSA compliant standards. Enbiosis licenses Powered by Enbiosis® blends to global food, beverage, and nutraceutical companies across multiple product formats and regions. UK Tech Rocketship Gold Winner | Peer-reviewed publications | Patent-protected formulations | FDA and EFSA compliant ingredients | 16 countries
Verified activity
Signals from ENBIOSIS Biotechnology
4 published signals
Research & Knowledge
ENBIOSIS Biotechnology conducted an interview with NutraIngredients discussing gut-eye axis research, a randomised controlled trial in dry eye disease, and over 30 companies in discussions since completing a pilot study.
Reported by ENBIOSIS Biotechnology
Capital & Finance
ENBIOSIS Biotechnology welcomed Yıldız Techno GSYF as an investor.
Reported by Ömer ÖZKAN
Presence & Recognition
ENBIOSIS Biotechnology has been named a Top 10 Finalist for the Global Food Tech Awards 2026, EMEA Heat
Reported by ENBIOSIS Biotechnology
Research & Knowledge
Enbiosis Biotechnology uses Digital Twin and AI to power its microbiome-targeted formulation engineering.
Reported by ENBIOSIS Biotechnology